Abstract: This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from inflammatory diseases.

Abstract: An antibody binding to IL-13R?1, inhibiting IL-13 bioactivity and comprising a variable heavy and a variable light chain, characterized in that the variable heavy chain amino acid sequence CDR3 of said antibody is selected from the group consisting of the heavy chain CDR3 sequences of SEQ ID NO: 1, 3, 5, 7 or 9 is useful in the treatment of asthma and allergic diseases.

Abstract: This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from inflammatory diseases.

Abstract: This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from inflammatory diseases.

Abstract: The instant specification discloses an antibody binding to IL-13R?1, inhibiting IL-13 bioactivity and comprising a variable heavy and a variable light chain, characterized in that the variable heavy chain amino acid sequence CDR3 of this antibody is selected from the group consisting of the heavy chain CDR3 sequences of SEQ ID NO: 1, 3, 5, 7 or 9, and this antibody is useful in the treatment of asthma and allergic diseases.

Abstract: This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from inflammatory diseases.

Abstract: This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from inflammatory diseases.

Abstract: A three-dimensional map of the probability of brain or heart functional states is obtained based on electric or magnetic signals, or a combination of both measured in the surface of body. From signals, the statistical descriptive parameters are obtained and a map of its distribution is calculated. The map is the inverse solution of the problem based upon: a) the restriction of the solution to structures with high probability of generating electric activity using for this restriction an Anatomical Atlas and b) imposing that the solution belong to a pre-specified functional space. The probability is determined that this map belongs to a test group. The spatial and temporal correlations of the map are modeled as well as their dependence on experimental covariables. The resulting probabilities are coded in a pseudocolor scale and they are superimposed on a Anatomical Atlas for their interactive three-dimensional visualization.

Abstract: A three-dimensional map of the probability of brain or heart functional states is obtained based on electric and or magnetic signals measured in the surface of body. From said signals, the statistical descriptive parameters are obtained and a map of its distribution is calculated. The map is the inverse solution of the problem based upon: a) the restriction of the solution to structures with high probability of generating electric activity using for this restriction an Anatomical Atlas and b) imposing that the solution belong to a pre-specified functional space. The probability is determined that this map belongs to a test group. The spatial and temporal correlations of the map are modeled as well as their dependence on experimental covariables. The resulting probabilities are coded in a pseudocolor scale and they are superimposed on a Anatomical Atlas for their interactive three-dimensional visualization.